Mark Gelder

Mark Gelder

Company: Onconova Therapeutics Inc

Job title: Chief Medical Officer

Seminars:

Implementing Intermittent Dosing Schedules for Anti-RAS Therapeutics 12:00 pm

Read more

day: Pre-Conference Day Track E

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.